ARCHIVES

T-Cell Vaccines Cut Time To Protective Immunity

This article is from The Cancer Letter archive.

Vol. 28 No. 11 | November 25, 2005

Download PDF Visit The Full Archive

Related Articles

Doxil/Caelyx Survival 3 Weeks Longer Than Topotecan

November 28, 2003

CCOP RFA Response So Far Points To More Consortia Applications, Reasonable Geographic Distribution

August 20, 1982

FDA’s New Guideline Proposal Meets More NCI Objections

March 19, 1976

Poverty Play Key Role In Excess Cancer Deaths Among Minorities, President’s Cancer Panel Hears

July 26, 1991

Community Assn. Meeting Includes Provocative Workshops

January 31, 1975

Recompetition of $1.9 Mil. Primate Contract Approved

November 15, 1985